Product Information
TRIAMCINOLONE 0.1% PASTE is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $2.5834 per GM under NDC 70752014017. Its NADAC has been published 148 times since Dec 6, 2023.
FDA first approved this application on Dec 9, 2022. Its Orange Book therapeutic-equivalence code is AT.
Strength
1 mg/g
Manufacturer
Quagen Pharmaceuticals LLCNDC
70752014017
Classification
Generic
Dosage Form
PASTE
Route
DENTAL
Effective Date
9/23/2026
Active Ingredients
TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214582FDA Approved
12/9/2022
TE Code
AT
On Market Since
1/15/2023
Pharmacological Classes
Price Statistics
The NADAC for TRIAMCINOLONE 0.1% PASTE has been published 148 times since Dec 6, 2023, and over the history we have for it it has declined 24.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5834 per GM |
|---|---|
| All-time high | $3.7007 (Apr 10, 2024) |
| All-time low | $2.2775 (Nov 20, 2024) |
| 52-week high | $3.1050 |
| 52-week low | $2.5834 |
| Median price | $3.0560 |
| Average price | $3.0470 |
| Largest weekly change | -31.3% (Nov 20, 2024) |
| Weeks tracked | 148 |
| Tracking since | Dec 6, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TRIAMCINOLONE ACETONIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quagen Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
TRIAMCINOLONE ACETONIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIAMCINOLONE 0.1% PASTE?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMCINOLONE 0.1% PASTE, manufactured by Quagen Pharmaceuticals LLC, is $2.5834 per GM (NDC 70752014017), effective Sep 30, 2026.
How has the price of TRIAMCINOLONE 0.1% PASTE changed over time?
Over the history we have for it, the NADAC for TRIAMCINOLONE 0.1% PASTE has declined 24.5%. It has been tracked across 148 weekly CMS publications since Dec 6, 2023.
What are the highest and lowest recorded NADAC prices for TRIAMCINOLONE 0.1% PASTE?
Since Dec 6, 2023, the NADAC for TRIAMCINOLONE 0.1% PASTE has ranged from a low of $2.2775 (Nov 20, 2024) to a high of $3.7007 (Apr 10, 2024), with a median of $3.0560 per GM.
Are there cheaper alternatives to TRIAMCINOLONE 0.1% PASTE?
No other NADAC-published product currently shares the active ingredient and strength of TRIAMCINOLONE 0.1% PASTE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRIAMCINOLONE 0.1% PASTE?
TRIAMCINOLONE 0.1% PASTE (NDC 70752014017) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.